glp 1 prostate cancer Glucagon-like peptide receptor agonists and risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research Depicts Mechanisms of Prostate Cancer

Nature 566 , 115119 (2019)

doi: 10.1016/j.redox.2020.101674 86 OkoyeCNKorenSAWojtovichAP

However, further efforts are needed to standardize in vitro protocols for evaluating Epitalons biological activity and to clarify its precise molecular mechanisms, which remain only partially understood

Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Adipose Ti-EVs have been proven to play a key role in the link between obesity and cancer

In 2023, a randomized, double-blind, placebo-controlled, multicenter trial investigated the efficacy of tirzepatide over 24 weeks in patients with moderate-to-severe obesity and OSAS